Navigation Links
Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results
Date:2/13/2009

of life, increase the duration of life and resolve serious unmet medical healthcare needs and also to identify promising product candidates based on exceptional scientific development expertise, develop them in a rapid, cost-efficient manner, and to pursue commercialization and/or development partners when and where appropriate."

"We exist to make a difference for the better and these are important times to do just that."

    The Company expects to have a conference call on Tuesday, March 10, 2009.

About Pharmacyclics

Pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule drug development expertise to build a pipeline in oncology and immune diseases based on a wide range of targets, pathways and mechanisms. More information about the company, its technology, and products can be found at http://www.pharmacyclics.com. Pharmacyclics(R) and the "pentadentate" logo(R) are registered trademarks of Pharmacyclics, Inc.

NOTE: Other than statements of historical fact, the statements made in this press release about projected operating expenses, future plans and timelines for our preclinical studies and clinical trials, progress of and reports of results from preclinical studies and clinical trials, clinical development plans and product development and corporate partnering activities are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. The words "project," "believe," "will," "may," "continue," "plan," "expect," "intend," "anticipate," variations of such words, and similar expressions also identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. The forward-looking statements are not guarantees of future performance an
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth
2. Pharmacyclics Secures $5.0 Million in Debt Financing
3. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
4. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
5. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
6. Pharmacyclics Announces It Received Nasdaq Notification
7. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
8. YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
9. Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results
10. Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial Results
11. Corgenix Reports Second Quarter Fiscal 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... This news release is available in German . ... all too well: with the naked eye, you can see ... bird in the blur of branches through the telephoto lens ... story for researchers who are looking to study proteins, the ... at ETH Zurich,s Institute for Molecular Systems Biology, and her ...
(Date:5/17/2013)... May 17, 2013 •    First of its ... for sustainability ,     New facility will help solve ... , Syngenta unveiled its new crop research ... company’s RTP Innovation Center. The first of its kind, ... simulate any agricultural climate and precisely measure plant inputs ...
(Date:5/17/2013)...  Yongye International, Inc. (NASDAQ: YONG ) ... distributor of crop nutrient products in the ... on May 16, 2013, the special committee (the "Special ... Directors") was provided a letter (the "Letter") issued by ... Limited ("Abax") to Full Alliance International Limited ("Full Alliance"). ...
(Date:5/17/2013)... Miami, FL (PRWEB) May 17, 2013 Men’s ... at La-roche Posay ) and has been known ... itself. Although some men may be far from puberty, other ... be clogging pores, causing breakouts, and threatening skin with unsightly ... with advice from Men’s Health on how to ...
Breaking Biology Technology:Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2
... Dec. 9 Medivation, Inc.,(Nasdaq: MDVN ... that,Dimebon, its lead product candidate in development to ... novel mitochondrial,mechanism of action. In preclinical studies, Dimebon ... cell function: it promoted neurite outgrowth and it,preserved ...
... Dec. 9 AcelRx Pharmaceuticals, Inc.,today announced positive ... the,safety and efficacy of its lead product candidate, ... following knee replacement surgery.,The primary endpoint evaluated pain ... over the 12-hour study period compared to baseline.,Results ...
... Corporation,(Nasdaq: PRXL ), a leading global ... an alliance with Safe Implementation,of Treatments in Stroke ... with specialized capabilities in the area of stroke. ... to more than 800,investigator sites located in 40 ...
Cached Biology Technology:Medivation Presents New Data on Dimebon's Novel Mechanism of Action 2Medivation Presents New Data on Dimebon's Novel Mechanism of Action 3Medivation Presents New Data on Dimebon's Novel Mechanism of Action 4AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain 2AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain 3PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies 2PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies 3PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies 4
(Date:5/17/2013)... The AGA Research Foundation announced a new grant that ... gut microbiota, one of today,s most exciting areas of ... AGA Research Awards Panel selected Andrew T. Chan, MD, ... Harvard Medical School, Boston, as the 2013 AGA-Elsevier Gut ... $25,000 of funding, commencing in July 2013, to test ...
(Date:5/17/2013)... New Jersey, and City University of New York have ... that effectively clears organisms to be viewed under microscopes. ... which is one of the few high-quality clearing solutions ... Drug Enforcement Administration (DEA) due to its use as ... vital for viewing organisms under a microscope. Without them, ...
(Date:5/17/2013)... a group of proteins in the brain responsible for ... target that could increase cell survival. , The discovery, ... and published in the EMBO journal with ... new therapies for stroke and other brain diseases. , ... which identified a protein, known as SUMO, responsible for ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3SUMO wrestling cells reveal new protective mechanism target for stroke 2
... Kenya (9 February 2011) Trees growing on farms ... trees in forests is declining every year, the number of ... International Year of Forest by the United Nations Forum on ... the Director General of the World Agroforestry Centre, highlighted the ...
... and concerns about global climate change are spurring ... fossil fuels to meet our transportation energy needs. ... possible alternatives to be liquid fuels derived from ... potential to be clean-burning, carbon-neutral and renewable. Some ...
... vaccine designed to fight a strain of avian flu that ... matches the current strain of bird flu to protect against ... Vaccine Development have found. The findings suggest public health ... by avian flu virus because they won,t have to wait ...
Cached Biology News:Putting trees on farms fundamental to future agricultural development 2Putting trees on farms fundamental to future agricultural development 3Putting trees on farms fundamental to future agricultural development 4Challenges for biofuels: New life cycle assessment report from Energy Biosciences Institute 2Challenges for biofuels: New life cycle assessment report from Energy Biosciences Institute 3Challenges for biofuels: New life cycle assessment report from Energy Biosciences Institute 4Saint Louis University findings: Don't pitch stockpiled avian flu vaccine 2
... is a simple, easy to use ... bacterial and yeast applications. The ... voltages and either one mm, two ... pressing the pulse button the electroporator ...
Request Info...
Maxi XL Hybridization Oven for Extra Large bottles. 6 bottle (70 mm) rotisserie + shaker tray available for simultaneous use. Includes linear and orbital shaker trays, 4 extra large bottles, pack o...
Shake 'n' Stack oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual)...
Biology Products: